Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Role of CTNNB1 in Endometrial Cancer.

Disease markers - 1 Jan 2022

Ledinek Živa, Sobočan Monika, Knez Jure

Abstract excerpt

Endometrial cancer (EC) is the most common gynaecologic malignancy in the developed countries. Recent evidence suggests that histopathological subtyping together with molecular subgrouping can lead to more accurate assessment of the risk profile for the patient. Clinical studies suggest the currently used molecular classification improves the risk assessment of women with endometrial cancer but does not explain...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta Catenin
Share to Endometrial and Cervical Cancer Treatments
Share to Endometrial Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic factors in colorectal cancer

Share to Mutation

Share to Neoplasm Recurrence, Local

Share to RNA Research and Splicing

Share to Wnt Signaling Pathway

Source

Open in PubMed Open full text

Identifiers

PMID: 35531470
DOI: 10.1155/2022/1442441
PMCID: PMC9072012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Role of CTNNB1 in Endometrial Cancer.PMID 35531470Read ↗

Mechanisms of mutant β-catenin in endometrial cancer progressionSemantic proximity Read ↗

The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.Semantic proximity Read ↗

Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis.Semantic proximity Read ↗

CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma: Correlation With Patient Outcome.Semantic proximity Read ↗

Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma.Semantic proximity Read ↗

Clinicopathologic Evaluation of CTNNB1 Mutations in High-Intermediate Risk Endometrial Endometrioid Carcinoma.Semantic proximity Read ↗

Molecular classification of endometrial cancers translated into practice.Semantic proximity Read ↗

[Progress in molecular classification of endometrial cancer and its clinical significance].Semantic proximity Read ↗

Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma.Semantic proximity Read ↗

CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.Semantic proximity Read ↗

Toward Biology-Driven Surveillance After Endometrial Cancer Treatment: A Molecular–Clinical Framework Integrating Recurrence PhenotypeSemantic proximity Read ↗

Immunohistochemical Nuclear Expression of β-Catenin as a Surrogate of CTNNB1 Exon 3 Mutation in Endometrial CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.